Ancon Medical has developed a revolutionary technology called Nanoparticle Biometric Tagging that gives medical professionals the capability to detect deadly diseases in a patient’s breath.
No matter what the disease, early diagnosis gives medical personnel more opportunities for treatment. NBT technology offers powerful capabilities to screen for a wide range of diseases with unprecedented sensitivity.
As a member of Medical Alley, the community of health industry leaders, Ancon Medical is committed to being a leader in the research and development of innovative healthcare technology.
Ancon Medical has developed a revolutionary technology called Nanoparticle Biometric Tagging (also known as Nanoparticle Biomarker Tagging) NBT that provides medical professionals with the capability to detect deadly diseases in a patient’s breath. These biomarkers are the signature of a disease and discovering them can give doctors the ability to make an early diagnosis and begin potentially life-saving treatment.
Focusing on the development of revolutionary, non-invasive disease screening technology, Ancon Medical Inc. is a medical device maker focusing on the development of revolutionary, non-invasive disease screening technology.
Ancon Medical presents unique solutions for the healthcare industry, providing a pathway to early detection capabilities that can be critical for treating deadly illnesses like lung cancer, tuberculosis and others. Read latest news and articles related to healthcare industry.
